empagliflozin decreases risk of kidney function decline in t2d: empa-reg outcome
Published 7 years ago • 6.9K plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
1:52
empa-kidney results: empagliflozin reduces kidney disease progression and cardiovascular deaths
-
6:06
esc 2019: empa-reg outcome - dr david fitchett
-
2:31
impact of empa-reg outcome
-
2:04
empa reg outcome trials - dr. milan chag
-
10:30
ada 2020: findings from empa-reg outcome trial — dr muthiah vaduganathan
-
30:29
heart failure spotlight: jardiance® (empagliflozin) tablets: the impact of empa-reg outcome
-
5:14
risk for heart failure modulate the effectiveness of empagliflozin ?
-
10:10
these 8 common medications damaged my kidney | stop using immediately
-
3:46
rogelio braceras, md: jardiance's results in the empa-reg outcome trial
-
3:21
empa ckd - 3 min trial summary
-
5:58
empagliflozin reduces cv death in patients with type 2 diabetes at high cv risk
-
11:52
safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease
-
2:41
fda approves empagliflozin for reducing kidney disease progression in ckd patients
-
6:28
emperor-reduced: empagliflozin benefits in hf patients irrespective of diabetes | milton packer
-
2:10
the new chronic kidney disease medicine and treatment option approved | empagliflozin
-
6:14
jardiance or empagliflozin: 9 must know clinical facts including side effects
-
38:48
radcliffe & cardionerds @aha22: empa-kidney: empagliflozin & cv outcomes in patients with ckd
-
2:58
diabetic kidney disease, animation
-
6:52
diabetic nephropathy